1.
Lazzaro C, Mazzanti NA, Parazzini F. Severe haematological toxicities in relapsed ovarian cancer treated with olaparib or niraparib: an Italian cost-minimization analysis. Grhta [Internet]. 2019 May 28 [cited 2024 Nov. 24];6(1). Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/464